Prescription opioid dispensing in Canada: an update on recent developments to 2018
Canada has been home to comparatively extreme developments in prescription opioid (PO) availability and related harms (e.g. morbidity, mortality) post-2000. Following persistent pan-Canadian increases in PO use, select control measures were implemented and PO dispensing levels—while only inconsisten...
| 發表在: | Journal of Pharmaceutical Policy and Practice |
|---|---|
| Main Authors: | , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Taylor & Francis Group
2020-12-01
|
| 主題: | |
| 在線閱讀: | http://dx.doi.org/10.1186/s40545-020-00271-x |